RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT03789695
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Irina Ermolaeva
- Registry
-
NCT03789695
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Unknown status
Technical summary
Registry record NCT03789695. Randomized; no masking; primary purpose other. Start 2018-11-14 (actual); primary completion 2021-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD
- Acronym
- RE-ELECT
- Condition
- Atrial Fibrillation
- Condition
- T2DM (Type 2 Diabetes Mellitus)
- Condition
- Chronic Kidney Diseases
- Intervention (Drug)
- Dabigatran Etexilate
- Lead sponsor
- Irina Ermolaeva
Record details
- Record id
cardio:ct-nct03789695- Content hash
f9d050e3b54281bc189cce409b05f91d5f573aebaddd209f99bc969fabc21e45